Trazadone and CBT no more effective than placebo for improving insomnia among long-term dialysis patients, finds study

by American College of PhysiciansCredit: Unsplash/CC0 Public DomainA clinical trial of more than 120 persons undergoing hemodialysis found that cognitive behavioral therapy for insomnia (CBT-I) o

Updated on: April 24,2024

Trazadone and CBT no more effective than placebo for improving insomnia among long-term dialysis patients, finds study

by American College of PhysiciansCredit: Unsplash/CC0 Public DomainA clinical trial of more than 120 persons undergoing hemodialysis found that cognitive behavioral therapy for insomnia (CBT-I) o

Updated on:April 24,2024

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on: December 20,2023

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on:December 20,2023

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib

Updated on: January 04,2024

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib

Updated on:January 04,2024

Coffee might give some men an edge battling prostate cancer

by Cara MurezFor some men battlingprostate cancer,drinking coffee may offer not just a quick pick-me-up but longer survival.Research is still in the early phases, but a new study finds an

Updated on: December 26,2023

Coffee might give some men an edge battling prostate cancer

by Cara MurezFor some men battlingprostate cancer,drinking coffee may offer not just a quick pick-me-up but longer survival.Research is still in the early phases, but a new study finds an

Updated on:December 26,2023

New radiation treatment for brain cancer offers better preservation of cognitive function

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicWhen it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better

Updated on: December 18,2023

New radiation treatment for brain cancer offers better preservation of cognitive function

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicWhen it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better

Updated on:December 18,2023

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on: April 23,2024

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on:April 23,2024

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on: October 15,2023

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on:October 15,2023

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on: December 19,2023

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on:December 19,2023

Ultrasound blasts potent glioblastoma drug into brain tumor

byNorthwestern UniversityCredit: CC0 Public DomainOne of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two proble

Updated on: December 22,2023

Ultrasound blasts potent glioblastoma drug into brain tumor

byNorthwestern UniversityCredit: CC0 Public DomainOne of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two proble

Updated on:December 22,2023

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on: January 04,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on:January 04,2024

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on: December 26,2023

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on:December 26,2023

Scientists uncover a missing link between poor diet and higher cancer risk

byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed

Updated on: April 28,2024

Scientists uncover a missing link between poor diet and higher cancer risk

byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed

Updated on:April 28,2024